Key result
Roux-en-Y gastric bypass yielded higher total weight loss than sleeve gastrectomy, with 44.1% of all patients achieving ≥20% total weight loss at 2 years.
Why the study?
Bariatric surgery is a cornerstone intervention offering substantial and sustainable weight loss for individuals with severe obesity.
Does metabolic bariatric surgery (SG or RYGB) improve weight loss outcomes in patients with obesity and Type 2 diabetes?
Cohort (n=186)
No
Does metabolic bariatric surgery (SG or RYGB) improve weight loss outcomes in patients with obesity and Type 2 diabetes?
Metabolic bariatric surgery provides substantial and sustainable weight loss in patients with obesity and Type 2 diabetes, with RYGB yielding higher total weight loss than SG.
Answers are grounded in this paper and cite their sources.
Supports meaningful 2-year weight loss after bariatric surgery in T2D; leaves open RYGB vs SG superiority pending randomized confirmation.
BACKGROUND: Bariatric surgery is a cornerstone intervention for individuals with severe obesity, offering substantial and sustainable weight loss. METHODS: This retrospective cohort study included 186 patients with obesity and Type2 diabetes who underwent sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) between 2009 and 2020 at University Hospital Ayr. Optimal clinical response weight loss was defined as excess weight loss (%EWL) ≥50 % or total weight loss (%TWL) ≥20 %. RESULTS: At 2-years post-surgery, 43.6 % achieved ≥50 %EWL, and 44.1 % achieved ≥20%TWL, with 31.8 % maintaining this at 5-years. Depending on the definition used, between 11.2 % and 45.9 % of patients experienced recurrent weight gain. BMI had significant positive association with %TWL but negative with %EWL (p < 0.05). RYGB had significantly higher %TWL compared to SG (p < 0.05). CONCLUSION: Most patients experienced weight loss which was maintained over time, however recurrent weight gain was noted. Pre-surgery BMI was significantly associated with weight changes.
No takes yet. Share an insight, caveat, or question.
Leyaro et al. (2024) conducted a cohort in Obesity and Type 2 diabetes (n=186). Roux-en-Y gastric bypass (RYGB) vs. Sleeve gastrectomy (SG) was evaluated on Optimal clinical response weight loss (excess weight loss ≥50% or total weight loss ≥20%) (p=<0.05). Roux-en-Y gastric bypass yielded higher total weight loss than sleeve gastrectomy, with 44.1% of all patients achieving ≥20% total weight loss at 2 years.
Synapse has enriched 10 related papers. Consider them for comparative context: